Diagnostic and Therapeutic Implications in a Case of Mixed Hepatitis C Virus (HCV) Infection

Authors Information
Article Notes and Dates
To Cite : Bruzzone B, De Leo P, Sticchi L, Canepa P, Rappazzo E, et al. Diagnostic and Therapeutic Implications in a Case of Mixed Hepatitis C Virus (HCV) Infection, Hepat Mon. 2017 ;17(3):e44774. doi: 10.5812/hepatmon.44774.
Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, Lloyd AR, et al. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology. 2010; 52(5): 1564-72[DOI][PubMed]
  • 2. Qiu P, Stevens R, Wei B, Lahser F, Howe AY, Klappenbach JA, et al. HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma. PLoS One. 2015; 10(4)[DOI][PubMed]
  • 3. Loulergue P, Mir O, Sogni P. Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C. AIDS. 2012; 26(5): 655-6[DOI][PubMed]
  • 4. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat. 2005; 12(3): 322-4[DOI][PubMed]
  • 5. Martin TC, Martin NK, Hickman M, Vickerman P, Page EE, Everett R, et al. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS. 2013; 27(16): 2551-7[DOI][PubMed]
  • 6. Chung E, Ferns RB, He M, Rigatti R, Grant P, McCormick A, et al. Ultra-deep sequencing provides insights into the virology of hepatitis C super-infections in a case of three sequential infections with different genotypes. J Clin Virol. 2015; 70: 63-6[DOI][PubMed]
  • 7. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis. 2007; 195(4): 519-24[DOI][PubMed]
  • 8. Qian KP, Natov SN, Pereira BJ, Lau JY. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat. 2000; 7(2): 153-60[DOI][PubMed]
  • 9. Cunningham EB, Applegate TL, Lloyd AR, Dore GJ, Grebely J. Mixed HCV infection and reinfection in people who inject drugs--impact on therapy. Nat Rev Gastroenterol Hepatol. 2015; 12(4): 218-30[DOI][PubMed]
  • 10. Abdelrahman T, Hughes J, Main J, McLauchlan J, Thursz M, Thomson E. Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment. Hepatology. 2015; 61(1): 88-97[DOI][PubMed]
  • 11. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005; 76(3): 327-32[DOI][PubMed]
  • 12. Norder H, Bergstrom A, Uhnoo I, Alden J, Weiss L, Czajkowski J, et al. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol. 1998; 36(10): 3066-9[PubMed]
  • 13. Di Maio VC, Cento V, Di Paolo D, Aragri M, De Leonardis F, Tontodonati M, et al. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. J Antimicrob Chemother. 2016; 71(3): 739-50[DOI][PubMed]
  • 14. Di Maio VC, Cento V, Di Paolo D, Lenci I, Aragri M, Verucchi G, et al. Virological failures to new direct acting antivirals in a real life setting may require unconventional regimens for re-treatment. J Hepatol. 2016; 64(2): 410[DOI]
  • 15. Lontok E, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, et al. Hepatitis C virus drug resistance-associated substitutions: State of the art summary. Hepatology. 2015; 62(5): 1623-32[DOI][PubMed]
  • 16. Rakhmanaliev E, Rui Z, Huang W, Poon KS, Cui WC, Mui J. K. . Next generation sequencing for HCV genotyping and optional identification of resistance-associated variants. J Hepatol. 2016;
  • 17. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol. 2010; 16(16): 2005-9[DOI][PubMed]
  • 18. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol. 1998; 72(2): 1640-6[DOI][PubMed]
  • 19. Di Liberto G, Roque-Afonso AM, Kara R, Ducoulombier D, Fallot G, Samuel D, et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology. 2006; 131(1): 76-84[DOI][PubMed]
  • 20. Midgard H, Bjoro B, Maeland A, Konopski Z, Kileng H, Damas JK, et al. Hepatitis C reinfection after sustained virological response. J Hepatol. 2016; 64(5): 1020-6[DOI][PubMed]
  • 21. Sarrazin C, Isakov V, Svarovskaia ES, Hedskog C, Martin R, Chodavarapu K, et al. Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies. Clin Infect Dis. 2017; 64(1): 44-52[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check